Icon Drugs Private Limited

Pharmaceutical company marketing and trading medicines under own brand.

2002 | Nagpur, Maharashtra (India) | Active
Last Updated:

Icon Drugs Profile

Key Indicators

  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 23 Year, 3 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 2.50 M
  • Revenue Growth 17.85%
  • Profit Growth 35.87%
  • Ebitda 17.02%
  • Net Worth 12.23%
  • Total Assets -2.32%

About Icon Drugs

Icon Drugs Private Limited (IDPL) is a Private Limited Indian Non-Government Company incorporated in India on 08 January 2002 and has a history of 23 years and three months. Its registered office is in Nagpur, Maharashtra, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.

The company currently has active open charges totaling ₹2.50 M.

Sushrut Dange, Umesh Dange, and Rachana Dange serve as directors at the Company.

Company Details

  • Location

    Nagpur, Maharashtra, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U24231MH2002PTC134479

  • Company No.

    134479

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    08 Jan 2002

  • Date of AGM

    30 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Mumbai

Industry

Pharma
Company report

Icon Drugs Private Limited

Explore comprehensive data for Icon Drugs Private Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Icon Drugs?

Board Members (3)

NameDesignationAppointment DateStatus
Sushrut Dange Country flag representing In Director 27-Feb-2017Current
Umesh Dange Country flag representing In Director 08-Jan-2002Current
Rachana Dange Country flag representing In Director 15-Mar-2022Current

Financial Performance of Icon Drugs.

Icon Drugs Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 17.85% increase. The company also saw a substantial improvement in profitability, with a 35.87% increase in profit. The company's net worth Soared by an impressive increase of 12.23%.

Icon Drugs revenue growth over time
Icon Drugs profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
17.85%
Revenue from Operations
17.85%
Total Assets
-2.32%
Profit or Loss
35.87%
Net Worth
12.23%
EBITDA
17.02%

What is the Ownership and Shareholding Structure of Icon Drugs?

In 2023, Icon Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹2.50 M

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions

  • Ing Vysya Bank Limited : 0.25 Cr

Latest Charge Details

DateLenderAmountStatus
27 Nov 2010Ing Vysya Bank Limited₹2.50 MOpen

How Many Employees Work at Icon Drugs?

Icon Drugs has a workforce of 13 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee growth trends for Icon Drugs Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Icon Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Icon Drugs's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Icon Drugs

Recent activity within the organization

  • Annual General Meeting

    Icon Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

  • Balance Sheet

    Icon Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.

  • Director Appointment

    Rachana Umesh Dange was appointed as a Director was appointed as a Director on 15 Mar 2022 & has been associated with this company since 3 years 1 month .

  • Director Appointment

    Sushrut Umesh Dange was appointed as a Director was appointed as a Director on 27 Feb 2017 & has been associated with this company since 8 years 1 month .

  • Charges

    A charge with Ing Vysya Bank Limited amounted to Rs. 2.50 M with Charge ID 10258295 was registered on 27 Nov 2010.

  • Director Appointment

    Umesh Babanrao Dange was appointed as a Director was appointed as a Director on 08 Jan 2002 & has been associated with this company since 23 years 3 months .

Frequently asked questions

  • What is the Incorporation or founding date of Icon Drugs Private Limited?

    Icon Drugs Private Limited was incorporated on 08 Jan 2002.

  • What is authorized share capital and paid-up capital of Icon Drugs Private Limited?

    The authorized share capital of Icon Drugs Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.

  • Who are the current board members & directors of Icon Drugs Private Limited?

    Currently 3 directors are associated with Icon Drugs Private Limited.

    • Sushrut Umesh Dange
    • Umesh Babanrao Dange
    • Rachana Umesh Dange
  • What is the registered address of Icon Drugs Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Icon Drugs Private Limited is Plot No. 1 Flat 201 Sai Dershan Complex Vivekanand Nagar, Wardha Road India, Nagpur, Maharashtra, 440015.

  • What is the corporate identification number (CIN) and company number of Icon Drugs Private Limited?

    The corporate identification number (CIN) of Icon Drugs Private Limited is U24231MH2002PTC134479 and the company number is 134479 as per Ministry of Corporate Affairs (MCA).

  • What has been the recent revenue trend for Icon Drugs Private Limited?

    According to the financial reports for the fiscal year 2023, the revenue trend for Icon Drugs Private Limited has risen by 17.85%.

  • How many employees does Icon Drugs Private Limited currently have?

    As Per 2023 financial reports, 13 employees are currently employed by Icon Drugs Private Limited.

  • What change has been observed in the net worth of Icon Drugs Private Limited, and by what percentage?

    The financial reports for the fiscal year 2023 indicates that The net worth of Icon Drugs Private Limited has experienced an upsurge of 12.23%.

  • What are the total open charges for Icon Drugs Private Limited?

    As per the financial statements for fiscal Year 2023, The total open charges for Icon Drugs Private Limited amount to ₹ 2.50 M.

  • When was the last Balance Sheet of Icon Drugs Private Limited filed with the ROC?

    The most recent Balance Sheet for Icon Drugs Private Limited was filed with the ROC on 31 Mar 2024.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial

People also Viewed

Similar Companies Based on Pharmaceutical Retailers & Distributors